During a presentation at the Texas BodyHacking Con conference in Texas, Justin Sanchez, the US Department of Defense DARPA Project Leader on Advanced Research, delivered a keynote address. In his speech, Sanchez warned about the inadmissibility of the introduction or use of biohackers that did not pass the necessary clinical trials of drugs. It turned out that a simple and seemingly indisputable truth needs the support of the authority of the Ministry of Defense. Many people gain access to untested medicines and advanced biotechnology. According to Sanchez, you should be more careful about the use of new biotechnology products. During the conference, one of the participants, right on the stage, introduced a drug that had previously been tested only on mice and had not undergone a proper clinical trial. Such cases are increasingly occurring publicly. So, three months ago on Facebook, a user introduced a cure for HIV that did not pass the necessary tests. There was also a case of introducing a “genetic cocktail” based on CRISPR technology and designed to accelerate muscle growth. Sanchez urged scientists and biotechnology fans not to fall into euphoria from the prospects opening up for biological developments. He emphasized that one should behave more carefully and responsibly. However, the biohackers themselves were skeptical of the expert’s words and emphasized the need for a quick demonstration of the developed drugs without conducting many years of testing and tests.